The long-term effects of a number of flavonoids (such as apigenin, luteolin and amentoflavone) and vinpocetine on the neutral endopeptidase (NEP) and angiotensin-converting enzyme (ACE) were investigated. It was shown that apigenin, luteolin and vinpocetin are able to induce the activity of both NEP and ACE associated with the inhibition of the proliferation of the neuroblastoma cell line SK-N-SH. Amentoflavone has no effect on either NEP or ACE activity. An additional enhancement of cellular NEP activity could be detected after the treatment of the cells with a combination of both arabinosylcytosine and either apigenin or luteolin. This effect supports the assumption that apigenin and luteolin influence directly the gene expression of NEP. Taking into account the significant role of NEP and ACE in the degradation of amyloid beta peptides, the induction of both enzymes by long-term treatment with apigenin, luteolin and vinpocetine may have a beneficial effect regarding the prevention of the formation of amyloid plaques and the effect of these substances may be discussed as neuroprotective.
HooperN.M. (1996) The biological roles of zinc and families of zinc metalloproteases. In: Zinc Metalloproteases in Health and Disease (ed HooperBM). Tayler & Francis Ltd, London, 1–21.
2.
GlabeC. (2000) Does Alzheimer disease tilt the scales of amyloid degradation versus accumulation?Nature Medicine, 6, 133–134.
3.
IwataN, TsubukiS, TakakiY, ShirotaniK, LuB, GerardNP, GerardC, HamaE, LeeHJ, SaidoTC. (2001) Metabolic regulation of Abeta by neprilysin. Science, 292, 1550–1552.
4.
YasojimaK, AkiyamaH, McGeerEG, McGeerPL. (2001) Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide. Neuroscience Letters, 297, 97–100.
KakinumaY, HamaH, SugiyamaF, YagamiK, GotoK, MurakamiK, FukamizuA. (1998) Anti-apoptotic action of angiotensin fragments to neuronal cells from angiotensinogen knockout mice. Nature Medicine, 4, 1078–1080.
7.
AlbrechtD, BroserM, KrugerH. (1997) Excitatory action of angiotensins II and IV on hippocampal neuronal activity in urethane anesthetized rats. Regulatory Peptides, 70, 105–109.
8.
KramarEA, HardingJW, WrightJW. (1997) Angiotensin II- and IV-induced changes in cerebral blood flow. Roles of AT1, AT2, and AT 4 receptor subtypes. Regulatory Peptides, 68, 131–138.
9.
ChenY, ZhengR, JiaZ, JuY. (1990) Flavonoids as superoxide scavengers and antioxidants Free Radical Biology & Medicine, 9, 19–21.
10.
MenonLG, KuttanR, KuttanG. (1995) Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Letters, 95, 221–225.
11.
FerrandizML, AlcarazMJ. (1991) Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids. Agents and Action, 32, 283–288.
12.
DuarteJ, VizcainoFP, UtrillaP, JimenezJ, TamargoJ, ZarzueloA. (1993) Vasodilatory effct of flavonoids in rat aortic smooth muscle. Structure-activity relationships. General Pharmacology, 24, 857–862.
13.
HayashiT, SawaK, KawasakiM, ArisawaM, ShimizuM, MoritaN. (1988) Inhibition of cow's milk xanthine oxidase by flavonoids. Journal of Natural Products, 51, 345–348.
14.
FerriolaPC, CodyY, MiddletonJrE. (1989) Protein kinase C inhibition by plant flavonoids. Kinetic mechanisms and structure-activity relationships. Biochemical Pharmacology, 38, 1617–1624.
15.
KuppusamyUR, DasNP. (1992) Effects of flavonoids on cyclic AMP phosphodiesterase and lipid mobilization in rat adipocytes. Biochemical Pharmacology, 44, 1307–1315.
16.
AyoubS, MelzigMF. (2006) Induction of neutral endopeptidase (NEP) activity of SK-N-SH cells by natural compounds from green tea. Journal of Pharmacy and Pharmacology, 58, 495–501.
17.
Le BarsP, KatsMM, NancyB, ItilTM, FreedmanAM, SchatzbergAF. (1997) A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. Journal of the American Medical Association, 278, 1327–1332.
18.
DeFeudisFrancis V. (1998) Ginkgo biloba extract (Egb 761): From chemistry to the clinic / Francis V. DeFeudis. – Wiesbaden: Ullstein Medical, 11–15.
LorinczC, SzaszK, KisfaludyL. (1976) The synthesis of ethyl apovincaminate. Arzneimittelforschung, 26, 1907.
21.
BereczkiD, FeketeI. (1999) A systematic review of vinpocetine therapy in acute ischaemic stroke. European Journal of Clinical Pharmacology, 55, 349–352.
22.
ImamotoT, TanabeM, ShimamotoN, KawazoeK, HirataM. (1984) Cerebral circulatory and cardiac effects of vinpocetine and its metabolite, apovincaminic acid, in anaesthetized dogs. Arzneimittelforschung, 34, 161–169.
23.
StolcS. (1999) Indole derivatives as neuroprotectants. Life Sciences, 65, 1943–1950.
24.
GrafK, KunkelK, ZhangM, GrafeM, SchultzK, SchudtC, BirocS, FleckE, KunkelG. (1995) Activation of adenylate cyclase and phosphodiesterase inhibition enhance neutral endopeptidase activity in human endothelial cells. Peptides, 16, 1273–1278.
25.
TheirM, RoebE, BreuerB, BayerTA, HalfterH, WeisJ. (2000) Expression of matrix metalloproteinase-2 in glial and neuronal tumor cell lines: inverse correlation with proliferation rate. Cancer Letters, 149, 163–170.
26.
UeharaC, InoK, SuzukiT, KajiyamaH, KikkawaF, NagasakaT, MizutaniS. (2001) Up regulation of neutral endopeptidase expression and enzymatic activity during the differentiation of human choriocarcinoma cells. Placenta, 22, 540–549.
27.
DayRM, YangY, SuzukiYJ, StevensJ, PathiR, PerlmutterA, FanburgBL, LanzilloJJ. (2001) Bleomycin upregulates gene expression of angiotensin-converting enzyme via mitogen-activated protein kinase and early growth response 1 transcription factor. American Journal of Respiratory Cell and Molecular Biology, 25, 613–619.
28.
PearseDD, PereiraFC, MarcilloAE, BatesML, BerrocalYA, FilbinMT, BungeMB. (2004) cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nature Medicine, 10, 610–616.
29.
WolozinB, LeschP, LebovicsR, SunderlandT. (1993) Olfactory neuroblasts from Alzheimer donors: studies on APP processing and cell regulation. Biological Psychiatry, 34, 824–838.
30.
KoWC, ShihCM, LaiYH, ChenJH, HuangHL. (2004) Inhibitory effects of flavonoids on phosphodiesterase isoenzymes from guinea pig and their structure activity relationships. Biochemical Pharmacology, 68, 2087–2094.
31.
PatilCS, SinghVP, SatyanarayanPS, JainNK, SinghA, KulkarniSK. (2003) Protective effect of flavonoids against aging- and lipopolysaccharide-induced cognitive impairment in mice. Pharmacology, 69, 59–67.
32.
ManachC, RegeratF, TexierO, AgulloG, DemigneC, RemesyC. (1996) Bioavailability, metabolism and physiological impact of 4-oxo-flavonoids. Nutrition Research, 16, 517–544.
33.
PiettaP, GardanaC, MauriPL. (1997) Identification of Gingko biloba flavonol metabolites after oral administration to humans. Journal of Chromatography, 693, 249–255.
34.
ChiuPJ, TetzloffG, AhnHS, SybertzEJ. (1988) Comparative effects of vinpocetine and 8-Br-cyclic GMP on the contraction and 45Ca-fluxes in the rabbit aorta. American Journal of Hypertension, 11, 262–268.
35.
KanedaT, ShimizuK, UrakawaN, KajyoS. (2004) Effects of various selective phosphodiesterase inhibitors on carbachol-induced contraction and cyclic nucleotide contents in guinea pig taenia coli. The Journal of Veterinary Medical Science, 66, 1047–1052.
36.
MiyamotoM, MurphyTH, SchnaarRL, CoyleJT. (1989) Antioxidants protect against glutamateinduced cytotoxicity in a neuronal cell line. The Journal of Pharmacology and Experimental Therapeutics, 250, 1132–1140.
LohmannA, DinglerE, SommerW, SchafferK, WoberW, SchmidtW. (1992) Bioavailability of vinpocetine and interference of the time of application with food intake. Arzneimittelforschung, 42, 914–917.
39.
MiskolcziP, KormaK, PolgarM, VereczkeyL. (1990) Pharmacokinetics of vinpocetine and its main metabolite apovincaminic acid before and after the chronic oral administration of vinpocetine to humans. European Journal of Drug Metabolism and Pharmacokinetics, 15, 1–5.
40.
GulyasB, HalldinM, KarlssonP, ChouYH, SwahnCG, BonockP, ParaczaiM, FardeL. (1999) Brain uptake and plasma metabolism of [11C] vinpocetine: a preliminary PET study in a cynomolgus monkey. Journal of Neuroimaging, 9, 217–222.
41.
GulyasB, HalldinC, FardeL. (2002) PET studies on the uptake and regional distribution of [11C] vinpocetine in human subjects. Acta Neurological Scandinavica, 106, 325–332.
42.
BormannH., MelzigMF. (2000) Inhibition of metallopeptidase by flavonoids and related compounds. Pharmazie, 55, 129–132.
43.
LabarcaC, PaigenK. (1980) A simple, rapid and sensitive DNA assay procedure. Analytical Biochemistry, 102, 344–352.
44.
RagoR, MitchenJ, WildingG. (1990) DNA fluorometric assay in 96-well tissue culture plates using Hoechst 33258 after cell lysis by freezing in distilled water. Analytical Biochemistry, 191, 31–34.
